Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
22.61
+1.36 (6.40%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Ultragenyx Pharmaceutical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -575 | -569 | -607 | -707.42 | -454.03 | |
| Depreciation & Amortization | 35 | 36 | 26 | 18.22 | 13.24 | |
| Asset Writedown & Restructuring Costs | - | - | - | 75.03 | - | |
| Loss (Gain) From Sale of Investments | -4 | -13 | -13 | 22 | 48.67 | |
| Stock-Based Compensation | 153 | 158 | 135 | 130.38 | 104.95 | |
| Other Operating Activities | -52 | -40 | - | 21.09 | 11.71 | |
| Change in Accounts Receivable | -31 | -34 | -23 | -12.07 | -5.43 | |
| Change in Inventory | -6 | -11 | -7 | -9.7 | -3.12 | |
| Change in Accounts Payable | 24 | 47 | -1 | 79.85 | 32.31 | |
| Change in Unearned Revenue | - | - | - | - | -57.49 | |
| Change in Other Net Operating Assets | -10 | 12 | 15 | 3.8 | -29.51 | |
| Operating Cash Flow | -466 | -414 | -475 | -380.47 | -338.7 | |
| Capital Expenditures | -6 | -7 | -44 | -116.12 | -73.09 | |
| Cash Acquisitions | - | - | - | -75.03 | - | |
| Sale (Purchase) of Intangibles | -15 | -13 | -3 | -30 | - | |
| Investment in Securities | 258 | 4 | 221 | -69.66 | -121.34 | |
| Other Investing Activities | -1 | -2 | -6 | -0.84 | -0.94 | |
| Investing Cash Flow | 236 | -18 | 168 | -291.65 | -195.37 | |
| Issuance of Common Stock | 86 | 392 | 387 | 10.81 | 119.04 | |
| Other Financing Activities | 392 | 7 | 1 | 490.4 | -0.49 | |
| Financing Cash Flow | 478 | 399 | 388 | 501.21 | 118.55 | |
| Foreign Exchange Rate Adjustments | 4 | -2 | - | -1.08 | -1.19 | |
| Net Cash Flow | 252 | -35 | 81 | -171.98 | -416.71 | |
| Free Cash Flow | -472 | -421 | -519 | -496.59 | -411.79 | |
| Free Cash Flow Margin | -70.13% | -75.18% | -119.59% | -136.68% | -117.18% | |
| Free Cash Flow Per Share | -4.79 | -4.65 | -7.06 | -7.10 | -6.07 | |
| Cash Income Tax Paid | 4 | - | - | - | - | |
| Levered Free Cash Flow | -251.13 | -207 | -312.54 | -370.58 | -244.82 | |
| Unlevered Free Cash Flow | -212.38 | -167.63 | -271.29 | -343.7 | -226.43 | |
| Change in Working Capital | -23 | 14 | -16 | 60.24 | -63.24 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.